Tg Therapeutics, Inc.
TGTX
Revenue
192.57M
▲30.87M▲19.09%
3 Months ChangeAssets
1.06B
▲38.23M▲3.73%
3 Months ChangeLiabilities
415.23M
▼-2.57M▼-0.6158%
3 Months ChangeFree Cash Flow
-28.74M
▼-20.53M▼-250.19%
12 Months ChangeRevenue/Cost Of Revenue
Loading...
Net Profit/Loss
Loading...
Assets/Liabilities
Loading...
Cash Flows
Loading...
Loading...
Loading...
Recent Quarterly and Annual Filings
2026-02-26
Form 8-K
ID: 0001437749-26-005733
2026-01-13
Form 8-K
ID: 0001437749-26-001194
2025-11-05
Form 10-Q
ID: 0001437749-25-033363
2025-11-03
Form 8-K
ID: 0001437749-25-032658
2025-08-08
Form 10-Q
ID: 0001437749-25-025745
2025-08-04
Form 8-K
ID: 0001437749-25-024480
2025-06-13
Form 8-K
ID: 0001437749-25-020335
2025-05-09
Form 10-Q
ID: 0001437749-25-015804
2025-05-05
Form 8-K
ID: 0001437749-25-014402
2025-03-03
Form 8-K
ID: 0001437749-25-005802